Biotechnology Ultrasector Valuation
| BIPIX Fund | USD 40.63 0.30 0.73% |
At this time, the entity appears to be fairly valued. Biotechnology Ultrasector shows a prevailing Real Value of $40.1 per share. The current price of the fund is $40.63. We determine the value of Biotechnology Ultrasector from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Biotechnology Ultrasector's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Biotechnology Ultrasector shows a prevailing Real Value of $40.1 per share. The current price of the fund is $40.63. We determine the value of Biotechnology Ultrasector from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Biotechnology Ultrasector is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotechnology Mutual Fund. However, Biotechnology Ultrasector's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 40.63 | Real 40.1 | Hype 40.63 | Naive 42.13 |
The intrinsic value of Biotechnology Ultrasector's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotechnology Ultrasector's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biotechnology Ultrasector Profund helps investors to forecast how Biotechnology mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotechnology Ultrasector more accurately as focusing exclusively on Biotechnology Ultrasector's fundamentals will not take into account other important factors: Biotechnology Ultrasector Total Value Analysis
Biotechnology Ultrasector Profund is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biotechnology Ultrasector fundamentals before making investing decisions based on enterprise value of the companyBiotechnology Ultrasector Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Biotechnology suggests not a very effective usage of assets in July.About Biotechnology Ultrasector Valuation
Our relative valuation model uses a comparative analysis of Biotechnology Ultrasector. We calculate exposure to Biotechnology Ultrasector's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biotechnology Ultrasector's related companies.The index is designed to measure the performance of biotechnology companies included in the SP Total Market Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80 percent of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |